Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-02 · accession 0001209191-22-026674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-03 | 2022-05-02 | VKTX | FOEHR MATTHEW W | Dir | P - Purchase | $2.47 | +45.0K | 111.2K | +68% | +$111.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2022-05-02 | P | A | 45,000 | $2.47 | 111,250 | D | — | — |